Flora Corporatio

Why is Flora Corporation Ltd falling/rising?

As of 11-Aug, Flora Corporation Ltd's stock price is rising to 8.09, driven by strong short-term performance and an attractive valuation despite long-term underperformance. The stock has outperformed its sector recently, accumulating a total return of 11.74% over three days, while trading at a discount relative to peers.

As of 11-Aug, Flora Corporation Ltd's stock price is rising, currently at 8.09, reflecting a change of 0.19 or 2.41%. This increase can be attributed to several factors. The stock has outperformed its sector by 6.7% today and has shown a consecutive gain over the last three days, accumulating a total return of 11.74% during this period. Additionally, the stock has experienced a significant increase of 6.45% over the past week, contrasting sharply with the Sensex, which has declined by 0.35%.<BR><BR>Despite the positive short-term performance, it is important to note that the stock has a history of underperformance, with a year-to-date return of 6.03% compared to a decline of 8.29% in the Sensex. However, the stock is trading at a discount relative to its peers, with a Price to Book Value of 1.4, indicating an attractive valuation. Furthermore, while the stock has generated a negative return of -37.63% over the past year, its profits have increased by 19%, resulting in a PEG ratio of 0.1, which suggests potential for future growth.<BR><BR>In summary, the recent rise in Flora Corporation Ltd's stock price is primarily driven by strong short-term performance metrics and an attractive valuation compared to its peers, despite the long-term challenges it faces.

Which are the latest news on Flora Corporatio?

When is the next results date for Flora Corporation Ltd?

The next results date for Flora Corporation Ltd is 14 August 2026.

The next results date for Flora Corporation Ltd is scheduled for 14 August 2026.

What does Flora Corporatio do?

Flora Corporation Ltd operates in the Marine & Fisheries, Scrap, and Dairy Products sectors as a Micro Cap company. As of March 2026, it reported net sales of 26 Cr and a net profit of 4 Cr.

Overview:<BR>Flora Corporation Ltd is engaged in the business of Marine & Fisheries Products, Scrap Products, and Dairy Products, operating within the Trading & Distributors industry and categorized as a Micro Cap company.<BR><BR>History:<BR>Flora Corporation Ltd was incorporated on 22 March, 1988. The company underwent a status change regarding its subsidiary, M/s. VCR8 Media Private Ltd, which was disinvested as per a Special Resolution passed on 24th April, 2018. The latest quarterly results reported net sales and profit for the period ending March 2026.<BR><BR>Financial Snapshot:<BR>- Net Sales: 26 Cr (Quarterly Results - Mar 2026)<BR>- Net Profit: 4 Cr (Quarterly Results - Mar 2026)<BR>- Market Cap: INR 7 Cr (Micro Cap)<BR><BR>Key Metrics:<BR>- P/E: 24.00<BR>- Industry P/E: 22<BR>- Dividend Yield: 0.00%<BR>- Debt Equity: -0.45<BR>- Return on Equity: 5.65%<BR>- Price to Book: 1.33<BR><BR>Contact Details:<BR>Address: Plot No 57 Text Book Colony, Secunderabad Telangana: 500009<BR>Email: csfloracorp@gmail.com<BR>Website: http://www.floracorp.in

How big is Flora Corporatio?

As of 10th June, Flora Corporation Ltd has a market capitalization of 7.00 Cr, classifying it as a Micro Cap company, with recent Net Sales of 84.52 Cr and a Net Profit of 0.29 Cr. Specific values for Shareholder's Funds and Total Assets are not available.

As of 10th June, Flora Corporation Ltd has a market capitalization of 7.00 Cr, which classifies it as a Micro Cap company.<BR><BR>In the latest four quarters, Flora Corporation reported Net Sales of 84.52 Cr and a Net Profit of 0.29 Cr.<BR><BR>The reporting period for the balance sheet data is the latest annual period. However, specific values for Shareholder's Funds and Total Assets are not available.

Who are in the management team of Flora Corporatio?

The management team of Flora Corporatio includes Rajesh Gandhi (Executive Director), Padamkumar Jabbarchand Gandhi (Independent Non-Executive Director), B Raja Singh (Independent Non-Executive Director), and Inturi Brahmaramba (Non-Executive Women Director).

The management team of Flora Corporatio includes the following individuals:<BR><BR>1. **Rajesh Gandhi** - Executive Director / Whole Time Director<BR>2. **Padamkumar Jabbarchand Gandhi** - Independent Non-Executive Director<BR>3. **B Raja Singh** - Independent Non-Executive Director<BR>4. **Inturi Brahmaramba** - Non-Executive Women Director<BR><BR>If you have any more questions about the company or its management, feel free to ask!

Who are the peers of the Flora Corporatio?

Flora Corporatio's peers include Nyssa Corp., Mystic Electron., Worldwide Alumi., Enterprise Intl., Evoq Remedies, Hemo Organic, Aravali Sec, Triveni Enterpri, and A F Enterprises. In terms of returns, Hemo Organic leads with 102.09% over one year, while Flora Corporatio has -28.45%, better than A F Enterprises at -53.00%.

Peers: The peers of the Flora Corporatio are Nyssa Corp., Mystic Electron., Worldwide Alumi., Enterprise Intl., Evoq Remedies, Hemo Organic, Aravali Sec, Triveni Enterpri, and A F Enterprises.<BR><BR>Quality Snapshot: Excellent management risk is observed at Flora Corporatio, while Below Average management risk is found at Nyssa Corp., Worldwide Alumi., Enterprise Intl., Evoq Remedies, and A F Enterprises, and Average management risk is noted at Triveni Enterpri. Mystic Electron., Hemo Organic, and Aravali Sec do not qualify for management risk assessment. In terms of Growth, Flora Corporatio and the peers Nyssa Corp., Worldwide Alumi., Enterprise Intl., Evoq Remedies, A F Enterprises, and Triveni Enterpri are rated Below Average, while Mystic Electron., Hemo Organic, and Aravali Sec do not qualify. For Capital Structure, Flora Corporatio, Nyssa Corp., Worldwide Alumi., Enterprise Intl., Evoq Remedies, Triveni Enterpri, and A F Enterprises are rated Below Average, while only Flora Corporatio and Triveni Enterpri are rated Good, and Mystic Electron., Hemo Organic, and Aravali Sec do not qualify.<BR><BR>Return Snapshot: The peer with the highest 1-year return is Hemo Organic at 102.09%, while the peer with the lowest is A F Enterprises at -53.00%. Flora Corporatio's own 1-year return is -28.45%, which is better than A F Enterprises but worse than the highest return peer. Additionally, the peers Mystic Electron., Aravali Sec, and A F Enterprises have negative six-month returns.

Are Flora Corporation Ltd latest results good or bad?

Flora Corporation Ltd's latest Q4 FY26 results are poor, with a 61.70% decline in net profit and a 47.30% drop in revenue year-on-year, marking three consecutive quarters of declining revenues. Concerns about the company's viability are heightened by a decrease in promoter stake and low market capitalization.

Flora Corporation Ltd's latest results for Q4 FY26 indicate a challenging financial situation. The company reported a net profit of ₹4.20 crores, which is a significant decline of 61.70% year-on-year. Additionally, revenue fell sharply to ₹26.15 crores, down 47.30% compared to the same quarter last year. This marks the third consecutive quarter of declining revenues, raising concerns about the sustainability of the business.<BR><BR>While the operating margin improved to 16.33% from a negative margin in the previous quarter, it remains below the 22.15% achieved in Q4 FY25. The volatility in earnings and the substantial drop in both revenue and profit suggest underlying weaknesses in the company's operational performance.<BR><BR>Moreover, the decline in promoter stake from 30.20% to 28.13% over recent quarters, combined with zero institutional holdings, reflects a lack of confidence from insiders and professional investors. The company's low market capitalization of ₹7.00 crores raises further liquidity concerns.<BR><BR>Overall, the results can be characterized as poor, highlighting significant operational challenges and raising questions about the company's future viability.

Should I buy, sell or hold Flora Corporation Ltd?

Is Flora Corporatio overvalued or undervalued?

As of November 17, 2025, Flora Corporatio is considered undervalued with a PE ratio of 10.23, a PEG ratio of 0.07, and lower valuation metrics compared to peers, indicating a strong investment opportunity despite a recent stock price decline.

As of 17 November 2025, Flora Corporatio has moved from a grade of risky to very attractive, indicating a significant improvement in its valuation outlook. The company is currently undervalued, with a price-to-earnings (PE) ratio of 10.23, a price-to-book value of 1.74, and an EV to EBITDA ratio of 6.81. These ratios suggest that the stock is trading at a discount compared to its earnings and book value.<BR><BR>In comparison to its peers, Flora Corporatio's PE ratio is notably lower than that of Avanti Feeds, which stands at 16.84, and Mukka Proteins at 16.67, both of which are also rated very attractive. Additionally, Flora's PEG ratio of 0.07 highlights its growth potential relative to its valuation, further supporting the conclusion that it is undervalued. Despite a recent decline in stock price, with a one-year return of -14.36% compared to the Sensex's 9.50%, the fundamental metrics indicate that Flora Corporatio presents a compelling investment opportunity at its current valuation.

How has been the historical performance of Flora Corporatio?

Flora Corporatio experienced significant growth from March 2017 to March 2018, with net sales increasing from 9.18 Cr to 109.40 Cr and profit after tax rising from 0.01 Cr to 0.23 Cr, indicating a positive trend in revenue and profitability.

Answer:<BR>The historical performance of Flora Corporatio shows significant growth from the fiscal year ending March 2017 to March 2018.<BR><BR>Breakdown:<BR>In March 2018, Flora Corporatio reported net sales of 109.40 Cr, a substantial increase from 9.18 Cr in March 2017. The total operating income mirrored this growth, rising to 109.40 Cr from 9.18 Cr. The raw material cost also increased significantly to 108.10 Cr in March 2018, compared to no recorded costs in the previous year. Total expenditure, excluding depreciation, rose to 109.02 Cr from 9.06 Cr. Operating profit (PBDIT) increased to 0.39 Cr in March 2018 from 0.12 Cr in March 2017, while profit before tax surged to 0.34 Cr from 0.01 Cr. Consequently, profit after tax rose to 0.23 Cr from 0.01 Cr, leading to an earnings per share (EPS) of 0.26 in March 2018, up from 0.01 in March 2017. The operating profit margin decreased slightly to 0.34% from 1.29%, while the profit after tax margin improved to 0.21% from 0.05%. Overall, the financial performance indicates a positive trend in revenue and profitability for Flora Corporatio during this period.

Who are the top shareholders of the Flora Corporatio?

The top shareholders of Flora Corporatio are Muvva Sujatha with 8.2%, Tej Prakash Toshniwal at 3.61%, and individual investors collectively owning 65.04%. There are no institutional holdings from mutual funds or foreign institutional investors.

The top shareholders of Flora Corporatio include Muvva Sujatha, who holds the highest stake among promoters at 8.2%. The highest public shareholder is Tej Prakash Toshniwal, with a holding of 3.61%. Additionally, individual investors collectively own 65.04% of the company's shares. There are no institutional holdings from mutual funds or foreign institutional investors.

What is the technical trend for Flora Corporatio?

As of May 28, 2025, Flora Corporation's technical trend is mildly bearish, with mixed signals from indicators like the MACD, RSI, and moving averages, suggesting caution in the near term.

As of 28 May 2025, the technical trend for Flora Corporatio has changed from bearish to mildly bearish. The weekly MACD indicates a mildly bullish stance, while the monthly MACD is mildly bearish, suggesting mixed signals across different time frames. The weekly RSI is bearish, which adds to the cautious outlook. Moving averages on a daily basis are mildly bearish, reinforcing the overall bearish sentiment. However, both the weekly and monthly Bollinger Bands are bullish, indicating potential upward price movement. The KST shows a mildly bullish trend on the weekly but is bearish on the monthly, further complicating the picture. Dow Theory supports a mildly bullish view on both weekly and monthly charts. Overall, the current technical stance is mildly bearish with mixed indicators, suggesting caution in the near term.

Has Flora Corporatio declared dividend?

No Dividend History Available